AblaCor
Needham
About AblaCor
AblaCor™ Medical Corporation’s mission is to develop innovative products to significantly advance Atrial Fibrillation (AFib) treatment. The Company’s goal is to provide patients with long-term freedom from AFib without multiple ablation procedures. AblaCor’s first product, the CircumBlator™ AF Catheter Ablation System, is uniquely designed to deliver pulmonary vein isolation (PVI) in a “single-shot" circumferential ablation compared to currently marketed “point-by-point” and “balloon” technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Last round: Grant (Nov 2012)
- Website: ablacor.com
- Phone: +1 (781) 248 6841
Industries & Categories
Health Care, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/ablacor-334783 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.